Sandra Dubos

Overview

With over 12 years of experience in advising and supporting innovative companies in the life sciences sector, Sandra Dubos has developed a strong expertise in nurturing startups with high growth potential. She began her career as an engineer at Sanofi-Aventis, focusing on the development of processes for the purification of natural active ingredients through ultrafiltration. This technical foundation was further enhanced during her tenure at Alcimed, a marketing and strategy consulting firm, where she undertook both strategic and operational assignments. Prior to joining Kreaxi in 2018, Sandra served as an innovation business manager at Bpifrance Financement, managing a portfolio of over 200 companies and overseeing more than 150 financing dossiers. At Kreaxi, Sandra manages a diverse portfolio of nearly a dozen companies, with half of them operating in the health sector. Her investment approach is characterized by a focus on innovative startups in the life sciences and information and communication technology sectors, ranging from seed to later-stage transactions. This strategy aligns with Kreaxi's mission to invest in French and European tech companies with sales up to EUR 100 million. Sandra's role at Kreaxi involves not only financial investment but also active participation in the strategic direction and growth of the portfolio companies. Sandra's commitment to fostering innovation is further demonstrated through her involvement in the supervisory board of Nosopharm, a company specializing in exploring unconventional sources of antibiotics to combat antimicrobial resistance. Her appointment to the board underscores her dedication to advancing healthcare solutions and supporting companies that address critical global health challenges. Sandra's extensive experience and strategic insights continue to make her a valuable asset in the venture capital landscape, particularly in sectors poised for significant technological advancements and societal impact.

Investment Focus

• Innovative business models
• Scalable growth potential
• Strong management teams
• Alignment with Kreaxi's investment strategy

Portfolio Companies